Reuters / Astrazeneca Plc / Emergency Authorization April / House Representatives Tuesday

(Reuters) - AstraZeneca Plc expects its COVID-19 vaccine could receive U.S. Emergency Use Authorization at the beginning of April and could immediately deliver 30 million doses of the shot there, a top executive said at a hearing in the U.S. House of Representatives on Tuesday

Further articles on the same subject

Reuters / Astrazeneca Plc / Emergency Authorization April / House Representatives Tuesday

Logo alert
Add to feed Create your own feed

Loading
Loading

Finance

BOE Governor Bailey says risks to the UK economy remain tilted to the downside via @lizzzburden 

tweet picture

Global mkts start mixed to the new week as sentiment fluctuates between reflation optimism & inflation concerns. Nasdaq Futures drop markedly while European shares gain. Bonds lower w/US 10y yields jump >1.60% after Senate passed $1.9tn stimi program. Gold $1692. #Bitcoin  $49.8k.

tweet picture

AI, chips and aerospace: In its tech race with the U.S., China laid out plans to speed up development of advanced technologies over five years #WSJWhatsNow 

Here we go. Treasury cash held at the Fed continues to decline. This trend will accelerate as the government gets going on the $1.9 trillion package.

tweet picture

One year into the pandemic, we can clearly see that the social and economic impact of the virus is particularly hard for women. In response we must #ChooseToChallenge  women’s roles at home, at work and in our society. Read my latest blog post #IWD2021 

tweet picture

Morning Note: -Senate passes $1.9t plan -U.S. tech stocks struggle -Brent breaks $70 briefly

tweet picture

10-year US Treasury#yield  above 1.60%. Markets will force the #FederalReserve  to adjust forward guidance, perhaps as early as this week.

tweet picture

Meet the woman who runs a London publishing house specializing in printing novels by overlooked female authors #IWD  #IWD20212021 

Loading
Loading